Related Experiment Videos
Association of the myeloperoxidase -463G-->a polymorphism with lung cancer risk
L Le Marchand1, A Seifried, A Lum
1Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu 96813, USA.
Abstract:
Myeloperoxidase, which is released from neutrophils in response to various pulmonary insults including tobacco smoke, is suspected to play a carcinogenic role in the lung. A G-to-A substitution polymorphism in the promoter region of the MPO gene has been suggested in in vitro studies to decrease gene transcription. We tested the association of this polymorphism with lung cancer in a population-based case-control study of 323 cases and 437 controls of Caucasian, Japanese, or Native Hawaiian ancestry in Hawaii. We found a marked difference in the frequency of the variant A allele among Caucasians (26%), Japanese (17%), and Hawaiians (13%). Overall, the variant allele was somewhat less frequent in cases than controls (P = 0.13). Individuals with the A/A genotype were found to be at a 50% decreased risk compared to those with two G alleles (95% confidence interval, 0.2-1.3). Although not statistically significant, this inverse association was suggested in both sexes and two of the three ethnic groups studied. Heterozygotes were at no decreased risk. Further work needs to clarify the functional relevance of the A allele in vivo and to confirm the inverse association of the A/A genotype with lung cancer in large epidemiological studies.
Insights
Myeloperoxidase (MPO) gene variations may influence lung cancer risk. A specific MPO genotype showed a potential decreased risk in a population study, warranting further investigation.
Area of Science:
- Pulmonary Medicine
- Genetics
- Cancer Research
Background:
- Myeloperoxidase (MPO) is released from neutrophils during lung injury, with suspected carcinogenic roles.
- A promoter polymorphism (G-to-A substitution) in the MPO gene may reduce its transcription.
- Investigating MPO gene variations is crucial for understanding lung cancer etiology.
Purpose of the Study:
- To examine the association between an MPO gene promoter polymorphism and lung cancer risk.
- To assess if the MPO A allele frequency differs across ethnic groups (Caucasian, Japanese, Native Hawaiian).
- To determine the in vivo effect of the MPO A/A genotype on lung cancer susceptibility.
Main Methods:
- Population-based case-control study including 323 lung cancer cases and 437 controls.
- Analysis of MPO gene promoter polymorphism (G-to-A substitution) across different ethnicities.
- Statistical evaluation of allele and genotype frequencies in relation to lung cancer risk.
Main Results:
- Significant ethnic differences in the variant A allele frequency were observed (Caucasians 26%, Japanese 17%, Hawaiians 13%).
- The variant MPO allele was less frequent in lung cancer cases than controls (P = 0.13).
- Individuals with the MPO A/A genotype exhibited a potential 50% decreased lung cancer risk (95% CI, 0.2-1.3), though not statistically significant.
Conclusions:
- The MPO A/A genotype may be inversely associated with lung cancer risk.
- Further research is needed to confirm the functional significance of the MPO A allele in vivo.
- Larger epidemiological studies are required to validate the observed inverse association between the MPO A/A genotype and lung cancer.